Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Gore

Showing results (111-120 of 157) with videos related to

Pageof 16
Sort By:
European Journal of Cancer & Clinical Oncology|January 1, 1987
Priming reduces the bone marrow toxicity of carboplatinM E Gore, C A Hills, Z H Siddik, et al.
British Journal of Cancer|September 20, 2000
Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer: a phase II studyM J Allen, M Vaughan, A Webb, et al.
British Journal of Obstetrics and Gynaecology|September 24, 1999
Gastrostomy tubes in patients with recurrent gynaecological cancer and intestinal obstructionE Tsahalina, R P Woolas, P G Carter, et al.
Oral Oncology|July 1, 1997
Cisplatin and 5-fluorouracil for symptom control in advanced salivary adenoid cystic carcinomaM E Hill, D O Constenla, R P A'Hern, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 7, 2004
Preoperative predictors of suboptimal primary surgical cytoreduction in women with clinical evidence of advanced primary epithelial ovarian cancerE C Brockbank, T E J Ind, D P J Barton, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 10, 2009
Epirubicin, cisplatin and protracted venous infusion 5-Fluorouracil chemotherapy for advanced salivary adenoid cystic carcinomaP J Ross, E M Teoh, R P A'hern, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1997
Chemotherapy for symptom control in recurrent squamous cell carcinoma of the head and neckD O Constenla, M E Hill, R P A'Hern, et al.
Gynecologic Oncology|August 7, 2004
Attitudes to chemotherapy in patients with ovarian cancerR T Penson, F Dignan, M V Seiden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
High-dose melphalan for multiple myeloma: long-term follow-up dataD Cunningham, L Paz-Ares, M E Gore, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1990
Characterization of monoclonal antibodies reactive with normal resting, lactating and neoplastic human breastR A Skilton, H M Earl, M E Gore, et al.
Pageof 16

Showing results (111-120 of 157) with videos related to

Sort By:
Pageof 16
European Journal of Cancer & Clinical Oncology|January 1, 1987
Priming reduces the bone marrow toxicity of carboplatinM E Gore, C A Hills, Z H Siddik, et al.
British Journal of Cancer|September 20, 2000
Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer: a phase II studyM J Allen, M Vaughan, A Webb, et al.
British Journal of Obstetrics and Gynaecology|September 24, 1999
Gastrostomy tubes in patients with recurrent gynaecological cancer and intestinal obstructionE Tsahalina, R P Woolas, P G Carter, et al.
Oral Oncology|July 1, 1997
Cisplatin and 5-fluorouracil for symptom control in advanced salivary adenoid cystic carcinomaM E Hill, D O Constenla, R P A'Hern, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 7, 2004
Preoperative predictors of suboptimal primary surgical cytoreduction in women with clinical evidence of advanced primary epithelial ovarian cancerE C Brockbank, T E J Ind, D P J Barton, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 10, 2009
Epirubicin, cisplatin and protracted venous infusion 5-Fluorouracil chemotherapy for advanced salivary adenoid cystic carcinomaP J Ross, E M Teoh, R P A'hern, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1997
Chemotherapy for symptom control in recurrent squamous cell carcinoma of the head and neckD O Constenla, M E Hill, R P A'Hern, et al.
Gynecologic Oncology|August 7, 2004
Attitudes to chemotherapy in patients with ovarian cancerR T Penson, F Dignan, M V Seiden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
High-dose melphalan for multiple myeloma: long-term follow-up dataD Cunningham, L Paz-Ares, M E Gore, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1990
Characterization of monoclonal antibodies reactive with normal resting, lactating and neoplastic human breastR A Skilton, H M Earl, M E Gore, et al.
Pageof 16